Acquired resistance to sunitinib in human renal cell carcinoma cells is mediated by constitutive activation of signal transduction pathways associated with tumour cell proliferation.

Acquired resistance to sunitinib in human renal cell carcinoma cells is mediated by constitutive activation of signal transduction pathways associated with tumour cell proliferation.

Item
http://www.wikidata.org/entity/Q39213121
Analyses of potential predictive markers and survival data for a response to sunitinib in patients with metastatic renal cell carcinoma.Acquired resistance to temsirolimus in human renal cell carcinoma cells is mediated by the constitutive activation of signal transduction pathways through mTORC2.Sunitinib Treatment Enhances Metastasis of Innately Drug-Resistant Breast Tumors.Renal cell carcinoma: how to hit the targets?GLI2 expression levels in radical nephrectomy specimens as a predictor of disease progression in patients with metastatic clear cell renal cell carcinoma following treatment with sunitinib.Molecular mechanism mediating cytotoxic activity of axitinib in sunitinib-resistant human renal cell carcinoma cells.Molecular analysis of sunitinib resistant renal cell carcinoma cells after sequential treatment with RAD001 (everolimus) or sorafenib.The Wide Experience of the Sequential Therapy for Patients with Metastatic Renal Cell Carcinoma.HDAC-inhibition counteracts everolimus resistance in renal cell carcinoma in vitro by diminishing cdk2 and cyclin A.Characterization of mechanism involved in acquired resistance to sorafenib in a mouse renal cell cancer RenCa model.Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockade.Acquired tumor cell resistance to sunitinib by increased invasion and epithelial-mesenchymal transition in LL/2 murine lung cancer.Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinoma.Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal.Enhanced sensitivity to sorafenib by inhibition of Akt1 expression in human renal cell carcinoma ACHN cells both in vitro and in vivo.Integrated analysis of differentially expressed profiles and construction of a competing endogenous long non-coding RNA network in renal cell carcinomaCharacterisation of the Morphological, Functional and Molecular Changes in Sunitinib-Resistant Renal Cell Carcinoma Cells
P2860

Acquired resistance to sunitinib in human renal cell carcinoma cells is mediated by constitutive activation of signal transduction pathways associated with tumour cell proliferation.

Item
http://www.wikidata.org/entity/Q39213121
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Acquired resistance to sunitin ...... ith tumour cell proliferation.
@en
Acquired resistance to sunitin ...... ith tumour cell proliferation.
@nl
type
label
Acquired resistance to sunitin ...... ith tumour cell proliferation.
@en
Acquired resistance to sunitin ...... ith tumour cell proliferation.
@nl
prefLabel
Acquired resistance to sunitin ...... ith tumour cell proliferation.
@en
Acquired resistance to sunitin ...... ith tumour cell proliferation.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Acquired resistance to sunitin ...... ith tumour cell proliferation.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1464-410X.2012.11655.X
P433
P478
P577
P698